Rein Interest Income from 2010 to 2026
| RNTX Stock | 1.19 0.01 0.83% |
Interest Income | First Reported 2010-12-31 | Previous Quarter 460 K | Current Value 403.3 K | Quarterly Volatility 52.2 K |
Check Rein Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rein Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 76.1 K, Selling General Administrative of 16.7 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.31. Rein financial statements analysis is a perfect complement when working with Rein Therapeutics Valuation or Volatility modules.
Rein | Interest Income | Build AI portfolio with Rein Stock |
The evolution of Interest Income for Rein Therapeutics provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Rein Therapeutics compares to historical norms and industry peers.
Latest Rein Therapeutics' Interest Income Growth Pattern
Below is the plot of the Interest Income of Rein Therapeutics over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Rein Therapeutics' Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rein Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Interest Income | 10 Years Trend |
|
Interest Income |
| Timeline |
Rein Interest Income Regression Statistics
| Arithmetic Mean | 327,255 | |
| Geometric Mean | 323,818 | |
| Coefficient Of Variation | 15.96 | |
| Mean Deviation | 41,684 | |
| Median | 300,000 | |
| Standard Deviation | 52,231 | |
| Sample Variance | 2.7B | |
| Range | 160K | |
| R-Value | 0.72 | |
| Mean Square Error | 1.4B | |
| R-Squared | 0.52 | |
| Significance | 0 | |
| Slope | 7,467 | |
| Total Sum of Squares | 43.6B |
Rein Interest Income History
Other Fundumenentals of Rein Therapeutics
Rein Therapeutics Interest Income component correlations
Click cells to compare fundamentals
About Rein Therapeutics Financial Statements
Rein Therapeutics investors use historical fundamental indicators, such as Rein Therapeutics' Interest Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Rein Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 460 K | 403.3 K | |
| Interest Income | 460 K | 403.3 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Rein Stock Analysis
When running Rein Therapeutics' price analysis, check to measure Rein Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rein Therapeutics is operating at the current time. Most of Rein Therapeutics' value examination focuses on studying past and present price action to predict the probability of Rein Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rein Therapeutics' price. Additionally, you may evaluate how the addition of Rein Therapeutics to your portfolios can decrease your overall portfolio volatility.